Imperial Valley News
Washington, DC - In Fiscal Year 2013, companies filed a total of 145 final patent dispute settlements, of which 29 created potential “pay-for-delay” agreements between branded and generic drug companies, according to a new Federal Trade Commission staff report. Although the number of potential pay-for-delay settlements is down from FY 2012, it is similar to FY 2010 and 2011.
Washington, DC - Secretary of State John Kerry: " I’ll never forget hearing the news of the tsunami that struck in the Indian Ocean 10 years ago. The images were gut-wrenching: entire towns razed from Indonesia to Somalia; raging waters sweeping away people’s homes; hundreds of thousands killed and many more separated from their families.
Sacramento, California - Governor Edmund G. Brown Jr. today issued an emergency proclamation for Marin, Mendocino, San Mateo and Ventura counties due to the effects of severe winter storms that caused damage to roads and highways throughout the state as a result of mudflows, debris, flooding and erosion. Today's proclamation directs Caltrans to formally request immediate assistance through the Federal Highway Administration's Emergency Relief Program.
Washington, DC - The staff of the Federal Trade Commission sent a letter to a China-based developer of mobile applications directed to children, warning that the company may be in violation of the Children’s Online Privacy Protection Act (COPPA) Rule.
Washington, DC - For the first time in 70 years there'll be not a single veteran of World War II sitting in the House of Representatives or in the Senate when 114th Congress convenes on January 3, 2015, the Association of Mature American Citizens notes.
Washington, DC - Global pharmaceutical company Eli Lilly and Company has agreed to divest its Sentinel product line of medications for treating heartworm disease in dogs in order to settle FTC charges that its proposed $5.4 billion acquisition of Novartis Animal Health would likely be anticompetitive. Under the proposed settlement, Eli Lilly will divest its Sentinel product line and associated assets to the French pharmaceutical company, Virbac S.A.